Keywords: symbicort, launched, copd, uk, astrazeneca, 200/, turbohaler
Symbicort launched for COPD in UK
Article | 07 April 2003
AstraZeneca's Symbicort 200/ 6 Turbohaler and Symbicort 400/ 12Turbohaler (budesonide/eformoterol) have both been granted a licence in the UK for use in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
